4D pharma plc Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
4D pharma plc had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $2.96 million as of 2018-12-31, per its 20-F/A filed 2021-04-30.
Discontinued › Notes
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2021-04-30
- 2018-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $2.96M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2018-12-31 | $2.96M 20-F/A · filed 2021-04-30 |